Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
about
Molecular mechanisms of severe acute respiratory syndrome (SARS)A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.Nucleocapsid proteins: roles beyond viral RNA packagingDynamic effects of antibody-dependent enhancement on the fitness of virusesSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsSumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus.Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccinationCluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.Construction and characterization of calreticulin-HBsAg fusion gene recombinant adenovirus expression vector.The coronavirus nucleocapsid is a multifunctional protein.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.Emerging respiratory viruses: challenges and vaccine strategiesCo-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination.Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.Generation and characterization of a preventive and therapeutic HPV DNA vaccineEnhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvantDevelopment of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.Understanding the T cell immune response in SARS coronavirus infectionTreatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccinationMolecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).Development of a DNA vaccine targeting Merkel cell polyomavirusTargeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection.SARS vaccines: where are we?Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.Animal models in virus research: their utility and limitations.Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen.The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha.Severe acute respiratory syndrome
P2860
Q24799739-F196CD73-32C4-4BFB-AA1B-F2D2DEA9B2CEQ24816925-17A833C7-0D8D-4FD2-8C6E-6707BFB75D49Q26770021-FF31D5D9-0395-45A2-8A54-025781E790FCQ27472667-26C08F8A-E8E4-4DBB-8AF3-F8A94F764EBAQ28383088-873A7DB0-3D0A-412E-B826-C295E1E47DDFQ28764574-16D5FE4E-BC60-4410-9B94-ED2A306AF034Q33292110-94994118-0599-4084-9F53-DE8D837B7562Q33589738-0397C2B9-42BE-470E-A9C9-404DF3C6B983Q33864400-15599AA1-D50E-4B8E-8B07-C10633A48EE0Q33923717-57C94BAA-DE7B-424E-8CBF-0150BFF41E8CQ33935644-DE76EA09-60FA-447B-8FC6-639680BCB2CDQ34102257-2A26C993-621E-469E-AAA9-9D3863226186Q34193942-D620453E-18CA-4E4A-9DA1-1926C865BA9BQ34708423-EA5F868C-FC15-4AF6-9F9C-C901A5DE116EQ35070868-2744A7A7-F18A-4D1D-AFB5-7C2E2E3ED4E8Q35782004-3253F2EA-9A2A-4FE1-830A-E48A19DAFC2AQ35878909-228B5BE7-173B-47DD-B5D3-2B47E26C08FAQ36097106-B8446757-BA7E-4E18-A556-8977D031BB44Q36482161-D57661CA-10C9-4280-8B88-D4D4EC327FA8Q36593900-EE42F46F-AB68-4DD9-A9AC-FEBDD67FEEEBQ36684369-C7F91384-E387-48AE-9AED-DCA937A750CCQ36784740-B4E6838E-622F-493C-AF52-4D354B77697EQ36795319-31A057A9-1100-42B1-940F-BD8EA7D3F851Q36874310-057A58DC-24B1-46BF-A20C-938652E2A2B8Q37183997-6DAC08A7-ADE9-40A7-ADCD-4DB405ECD13EQ37200390-EEB8F8CC-4374-4FEB-A496-C6E2006D1311Q37295275-6ADD7185-7067-48D9-9281-23199C30C8A0Q37524036-4F210B8A-0574-4B4C-A789-8B077D925E04Q37597614-AE597E3D-ED16-4BEF-869A-F22C03477E1EQ38043556-45D5D7F5-7271-4CDE-AC7D-3884E331FDF9Q39395958-39B0BE9F-5EB8-42CB-B502-DE18E907F801Q39763675-A6E6B033-C96A-4E3C-8FFB-8A2C7DE90598Q56775278-9304016B-D819-46E2-8FF1-FCEBBD041195
P2860
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generation and characterizatio ...... piratory syndrome coronavirus.
@en
Generation and characterizatio ...... piratory syndrome coronavirus.
@nl
type
label
Generation and characterizatio ...... piratory syndrome coronavirus.
@en
Generation and characterizatio ...... piratory syndrome coronavirus.
@nl
prefLabel
Generation and characterizatio ...... piratory syndrome coronavirus.
@en
Generation and characterizatio ...... piratory syndrome coronavirus.
@nl
P2093
P2860
P1433
P1476
Generation and characterizatio ...... piratory syndrome coronavirus.
@en
P2093
Chien-Fu Hung
David A K Boyd
Jin Hyup Lee
Liangmei He
Mei-Cheng Wang
Pei-Jer Chen
Raphael Viscidi
Richard Roden
Shiwen Peng
P2860
P304
P356
10.1128/JVI.78.9.4638-4645.2004
P407
P577
2004-05-01T00:00:00Z